Patents by Inventor Griffith E. Altmann

Griffith E. Altmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11565015
    Abstract: A biological indicator with variable resistance may be controlled by moving a cap or housing of the biological indicator to cause the size of vents that allow flow of sterilant through the housing to decrease or increase in effective size. An indicator window may show a user the current resistance of the biological indicator, and may also show a readable indicator that may be captured by a scanner to allow a sterilizing cabinet to identify the current resistance. When the level of resistance shown by the readable indicator is not compatible with a sterilization cycle selected by a user, the procedure may be delayed and a notification provided to the user that a problem exists. The readable indicator may be a passive tag with a memory that allows information to be read and written, so that the biological indicator may carry data from one device to another.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: January 31, 2023
    Assignee: ASP Global Manufacturing GmbH
    Inventors: Yan Fang, Griffith E. Altmann, Behnam Amin, Jeremy Yarwood, Lawrence Y. Mok
  • Publication number: 20210386589
    Abstract: In an ophthalmic laser procedure, a lenticule is formed in the cornea and extracted from the cornea to accomplish vision correction. The ophthalmic laser system is used to form top and bottom lenticule incisions which intersect each other to form an isolated volume of corneal tissue in between. The volume of tissue includes a lenticular portion having a circular or oval shape and a side tab that protrudes from the peripheral of the lenticular portion. The side tab has a radial dimension between 0.5 and 5 mm and a width between 0.5 and 3 mm in. An entry cut is further formed from the anterior corneal surface to the top or bottom lenticule incisions to provide access to the lenticule. During extraction, the surgeon uses the surgical tool to grab the side tab to extract the lenticule.
    Type: Application
    Filed: August 30, 2021
    Publication date: December 16, 2021
    Inventors: Jose L. Garcia, Griffith E. Altmann
  • Patent number: 11110007
    Abstract: In an ophthalmic laser procedure, a lenticule is formed in the cornea and extracted from the cornea to accomplish vision correction. The ophthalmic laser system is used to form top and bottom lenticule incisions which intersect each other to form an isolated volume of corneal tissue in between. The volume of tissue includes a lenticular portion having a circular or oval shape and a side tab that protrudes from the peripheral of the lenticular portion. The side tab has a radial dimension between 0.5 and 5 mm and a width between 0.5 and 3 mm in. An entry cut is further formed from the anterior corneal surface to the top or bottom lenticule incisions to provide access to the lenticule. During extraction, the surgeon uses the surgical tool to grab the side tab to extract the lenticule.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: September 7, 2021
    Assignee: AMO Development, LLC
    Inventors: Jose L. Garcia, Griffith E. Altmann
  • Patent number: 10973688
    Abstract: An ophthalmic laser surgical system uses a confocal detector assembly to continuously detect a confocal signal during laser treatment, and based on the confocal signal, detects in real time a loss of tissue contact with the patient interface (PI) output surface. The detection is partly based on the change of reflectivity at the PI output surface when the optical interface changes from a lens-tissue interface to a lens-air interface. The behavior of the confocal signal upon loss of tissue contact is dependent on the treatment laser scan pattern being performed at the time of tissue contact loss. Thus, different confocal signal analysis algorithms are applied to detect tissue contact loss during different scans, such as the bed cut and side cut for a corneal flap. The real time confocal signal may also be used during eye docking to detect the establishment of tissue contact with the PI output surface.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: April 13, 2021
    Assignee: AMO Development, LLC
    Inventors: Harvey I. Liu, Mohammad Saidur Rahaman, Hong Fu, Griffith E. Altmann
  • Publication number: 20200289318
    Abstract: An ophthalmic laser surgical system uses a confocal detector assembly to continuously detect a confocal signal during laser treatment, and based on the confocal signal, detects in real time a loss of tissue contact with the patient interface (PI) output surface. The detection is partly based on the change of reflectivity at the PI output surface when the optical interface changes from a lens-tissue interface to a lens-air interface. The behavior of the confocal signal upon loss of tissue contact is dependent on the treatment laser scan pattern being performed at the time of tissue contact loss. Thus, different confocal signal analysis algorithms are applied to detect tissue contact loss during different scans, such as the bed cut and side cut for a corneal flap. The real time confocal signal may also be used during eye docking to detect the establishment of tissue contact with the PI output surface.
    Type: Application
    Filed: March 15, 2019
    Publication date: September 17, 2020
    Inventors: Harvey I. Liu, Mohammad Saidur Rahaman, Hong Fu, Griffith E. Altmann
  • Publication number: 20200289320
    Abstract: In an ophthalmic laser procedure, a lenticule is formed in the cornea and extracted from the cornea to accomplish vision correction. The ophthalmic laser system is used to form top and bottom lenticule incisions which intersect each other to form an isolated volume of corneal tissue in between. The volume of tissue includes a lenticular portion having a circular or oval shape and a side tab that protrudes from the peripheral of the lenticular portion. The side tab has a radial dimension between 0.5 and 5 mm and a width between 0.5 and 3 mm in. An entry cut is further formed from the anterior corneal surface to the top or bottom lenticule incisions to provide access to the lenticule. During extraction, the surgeon uses the surgical tool to grab the side tab to extract the lenticule.
    Type: Application
    Filed: March 15, 2019
    Publication date: September 17, 2020
    Inventors: Jose L. Garcia, Griffith E. Altmann
  • Publication number: 20200179550
    Abstract: A biological indicator with variable resistance may be controlled by moving a cap or housing of the biological indicator to cause the size of vents that allow flow of sterilant through the housing to decrease or increase in effective size. An indicator window may show a user the current resistance of the biological indicator, and may also show a readable indicator that may be captured by a scanner to allow a sterilizing cabinet to identify the current resistance. When the level of resistance shown by the readable indicator is not compatible with a sterilization cycle selected by a user, the procedure may be delayed and a notification provided to the user that a problem exists. The readable indicator may be a passive tag with a memory that allows information to be read and written, so that the biological indicator may carry data from one device to another.
    Type: Application
    Filed: February 12, 2020
    Publication date: June 11, 2020
    Inventors: Yan Fang, Griffith E. Altmann, Behnam Amin, Jeremy Yarwood, Lawrence Y. Mok
  • Patent number: 10632220
    Abstract: A biological indicator with variable resistance may be controlled by moving a cap or housing of the biological indicator to cause the size of vents that allow flow of sterilant through the housing to decrease or increase in effective size. An indicator window may show a user the current resistance of the biological indicator, and may also show a readable indicator that may be captured by a scanner to allow a sterilizing cabinet to identify the current resistance. When the level of resistance shown by the readable indicator is not compatible with a sterilization cycle selected by a user, the procedure may be delayed and a notification provided to the user that a problem exists. The readable indicator may be a passive tag with a memory that allows information to be read and written, so that the biological indicator may carry data from one device to another.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: April 28, 2020
    Assignee: ASP GLOBAL MANUFACTURING GMBH
    Inventors: Yan Fang, Griffith E. Altmann, Behnam Amin, Jeremy Yarwood, Lawrence Y. Mok
  • Publication number: 20180071421
    Abstract: A biological indicator with variable resistance may be controlled by moving a cap or housing of the biological indicator to cause the size of vents that allow flow of sterilant through the housing to decrease or increase in effective size. An indicator window may show a user the current resistance of the biological indicator, and may also show a readable indicator that may be captured by a scanner to allow a sterilizing cabinet to identify the current resistance. When the level of resistance shown by the readable indicator is not compatible with a sterilization cycle selected by a user, the procedure may be delayed and a notification provided to the user that a problem exists. The readable indicator may be a passive tag with a memory that allows information to be read and written, so that the biological indicator may carry data from one device to another.
    Type: Application
    Filed: September 15, 2016
    Publication date: March 15, 2018
    Inventors: Yan Fang, Griffith E. Altmann, Behnam Amin, Jeremy Yarwood, Lawrence Mok
  • Patent number: 8535376
    Abstract: In an embodiment, an aspheric IOL for use in a pseudophakic ocular system has no inherent spherical aberration. In an embodiment, an aspheric IOL for use in a pseudophakic ocular system has a controlled amount of inherent negative spherical aberration such that the IOL induces no spherical aberration in a converging wavefront from a cornea passing through the lens. An embodiment of the invention is directed to a family of aspheric IOLs made up of any two or more member aspheric IOLs each having different spherical aberration values and different lens shape factors. A lens constant, such as the well known A-constant, is kept constant throughout the family of lenses. An embodiment of the invention is directed to a multi-component accommodating intraocular lens (A-IOL). In a particular embodiment, the A-IOL introduces substantially no residual spherical aberration to a wavefront incident upon and passing through the A-IOL.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: September 17, 2013
    Assignee: Bausch & Lomb Incorporated
    Inventor: Griffith E. Altmann
  • Publication number: 20110098810
    Abstract: In an embodiment, an aspheric IOL for use in a pseudophakic ocular system has no inherent spherical aberration. In an embodiment, an aspheric IOL for use in a pseudophakic ocular system has a controlled amount of inherent negative spherical aberration such that the IOL induces no spherical aberration in a converging wavefront from a cornea passing through the lens. An embodiment of the invention is directed to a family of aspheric IOLs made up of any two or more member aspheric IOLs each having different spherical aberration values and different lens shape factors. A lens constant, such as the well known A-constant, is kept constant throughout the family of lenses. An embodiment of the invention is directed to a multi-component accommodating intraocular lens (A-IOL). In a particular embodiment, the A-IOL introduces substantially no residual spherical aberration to a wavefront incident upon and passing through the A-IOL.
    Type: Application
    Filed: October 28, 2010
    Publication date: April 28, 2011
    Inventor: Griffith E. Altmann
  • Patent number: 7931686
    Abstract: A thin intraocular lens for inhibiting posterior capsular opacification (PCO) includes an optic having an anterior concave region, a posterior concave region, a sharp edge which extends posteriorly and between the posterior concave region and at least a portion of an outer-most peripheral edge surface.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: April 26, 2011
    Assignee: Bausch & Lomb Incorporated
    Inventors: Jerome Vaudant, Gary A. Richardson, Griffith E. Altmann
  • Patent number: 7905917
    Abstract: In an embodiment, an aspheric IOL for use in a pseudophakic ocular system has no inherent spherical aberration. An embodiment of the invention is directed to a family of aspheric IOLs in which a lens constant, such as the well known A-constant, is kept constant throughout the family of lenses. An embodiment of the invention is directed to a multi-component accommodating intraocular lens (A-IOL) having substantially no inherent spherical aberration. An embodiment of the invention is directed to a family of member A-IOLs where each member A-IOL has a first (1) surface and a fourth (4) surface characterized by a radius and a conic constant that remain substantially constant over the power rage of the A-IOL family.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: March 15, 2011
    Assignee: Bausch & Lomb Incorporated
    Inventor: Griffith E. Altmann
  • Publication number: 20100079723
    Abstract: A toric ophthalmic lens having substantially zero spherical aberration for a first circular aperture having a first diameter and substantially zero spherical aberration for a second circular aperture having a second diameter, the first diameter being at least 4 mm and the second diameter being at least 3 mm, the first diameter being at least 0.5 mm larger than the second diameter. A series of ophthalmic lenses, each lens comprising a same spherical power as the other lenses in the set, and a unique cylindrical power, each lens comprising (i) a first toric surface, and (ii) a second surface, at least one of the first surface and the second surface being aspheric in a meridian, the lens having substantially zero spherical aberration for all circular optical zone diameters less than 4 mm.
    Type: Application
    Filed: October 1, 2008
    Publication date: April 1, 2010
    Inventors: Amanda C. Kingston, Griffith E. Altmann
  • Patent number: 7641337
    Abstract: An ophthalmic lens, comprising an optic including at least one photochromic region having a first chromaticity and a second region of lesser photochromaticity. A method of treating a subject having presbyopia or aniridia comprising applying to the subject's eye an ophthalmic lens comprising an optic including at least one photochromic region having a first chromaticity and a second region of lesser photochromaticity.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: January 5, 2010
    Assignee: Bausch & Lomb Incorporated
    Inventor: Griffith E. Altmann
  • Publication number: 20090265000
    Abstract: A thin intraocular lens for inhibiting posterior capsular opacification (PCO) includes an optic having an anterior concave region, a posterior concave region, a sharp edge which extends posteriorly and between the posterior concave region and at least a portion of an outer-most peripheral edge surface.
    Type: Application
    Filed: June 30, 2009
    Publication date: October 22, 2009
    Inventors: Jerome Vaudant, Gary A. Richardson, Griffith E. Altmann
  • Patent number: 7569073
    Abstract: A thin intraocular lens for inhibiting posterior capsular opacification (PCO) includes an optic having a sharp edge which extends posteriorly and between a posterior concave region and an outer-most peripheral edge surface that extends parallel to the optical axis.
    Type: Grant
    Filed: December 29, 2004
    Date of Patent: August 4, 2009
    Assignee: Bausch & Lomb Incorporated
    Inventors: Jerome Vaudant, Gary A. Richardson, Griffith E. Altmann
  • Publication number: 20090118828
    Abstract: A multi-element IOL, comprising an anterior lens element comprising a light-adjustable material responsive to light of a first wavelength, and a posterior lens element comprising a light blocker capable of blocking light of the first wavelength, and a method of inserting the multi-element IOL.
    Type: Application
    Filed: November 6, 2007
    Publication date: May 7, 2009
    Inventor: Griffith E. Altmann
  • Publication number: 20080300679
    Abstract: An IOL, comprising a first diffractive region, and a second diffractive region having a power of a different magnitude than the first diffractive region, the first region adapted to diffract substantially all light at a first selected wavelength projected therethrough into a single order of diffraction, and the second region adapted to diffract substantially all light at a second selected wavelength projected therethrough into a single order of diffraction.
    Type: Application
    Filed: June 1, 2007
    Publication date: December 4, 2008
    Inventor: Griffith E. Altmann
  • Publication number: 20080151183
    Abstract: An ophthalmic lens, comprising an optic including at least one photochromic region having a first chromaticity and a second region of lesser photochromaticity.
    Type: Application
    Filed: December 22, 2006
    Publication date: June 26, 2008
    Inventor: Griffith E. Altmann